Clinical and polysomnographic course of childhood narcolepsy with cataplexy

Brain

Volumn 136, Issue 12, 2013, Pages 3787-3795

  Pizza, Fabio ^a,b   Franceschini, Christian ^a,b,c   Peltola, Hanna ^d   Vandi, Stefano ^a,b   Finotti, Elena ^a,b   Ingravallo, Francesca ^e   Nobili, Lino ^f   Bruni, Oliviero ^g   Lin, Ling ^h   Edwards, Mark J ⁱ   Partinen, Markku ^d   Dauvilliers, Yves ^j   Mignot, Emmanuel ^h   Bhatia, Kailash P ⁱ   Plazzi, Giuseppe ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b IRCCS ISTITUTO DELLE SCIENZE NEUROLOGICHE DI BOLOGNA   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

^d Vitalmed Research Centre   (Finland)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f OSPEDALE NIGUARDA CA GRANDA   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h STANFORD UNIVERSITY   (United States)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j GUI DE CHAULIAC HOSPITAL   (France)

more..

Author keywords

Cataplexy; Children; Narcolepsy; Sleep; Sleepiness

Indexed keywords

OREXIN A;

AGE; ARTICLE; BODY MASS; BODY MOVEMENT; CATAPLEXY; CHILD; CHILDHOOD DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DISEASE COURSE; DISEASE DURATION; EMOTION; EPWORTH SLEEPINESS SCALE; FEMALE; FOLLOW UP; GENDER; HOSPITALIZATION; HUMAN; HYPNAGOGIC HALLUCINATION; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MUSCLE HYPOTONIA; MUSCLE WEAKNESS; NARCOLEPSY; NIGHT SLEEP; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REM SLEEP; SCHOOL CHILD; SLEEP PATTERN; SLEEP STAGE; SLEEP TIME; SLOW WAVE SLEEP; STREPTOCOCCUS INFECTION; VIDEORECORDING;

EID: 84890722534     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awt277     Document Type: Article

References (44)

1. American Academy of Sleep Medicine. ICSD-2-International classification of sleep disorders: diagnostic and coding manual. 2nd edn. Westchester, IL: American Academy of Sleep Medicine; 2005.
2. Aran A, Einen M, Lin L, Plazzi G, Nishino S, Mignot E. Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children. Sleep 2010; 33: 1457-64.
3. Aran A, Lin L, Nevsimalova S, Plazzi G, Hong SC, Weiner K. Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep 2009; 32: 979-83.
4. Broughton R, Dunham W, Newman J, Lutley K, Duschesne P, Rivers M. Ambulatory 24 hour sleep-wake monitoring in narcolepsy-cataplexy compared to matched controls. Electroencephalogr Clin Neurophysiol 1988; 70: 473-81.
5. Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, et al. Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 2006; 29: 581-93.
6. Cvetkovic-Lopes V, Bayer L, Dorsaz S, Maret S, Pradervand S, et al. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J Clin Invest 2010; 120: 713-9.
7. Dale RC. Post-streptococcal autoimmune disorders of the central nervous system. Dev Med Child Neurol 2005; 47: 785-91.
8. Dauvilliers Y, Gosselin A, Paquet J, Touchon J, Billiard M, Montplaisir J. Effect of age on MSLT results in patients with narcolepsy-cataplexy. Neurology 2004; 62: 46-50.
9. Dauvilliers Y, Montplaisir J, Molinari N, Carlander B, Ondze B, Besset A, et al. Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology 2001; 57: 2029-33.
10. Faraco J, Lin L, Kornum BR, Kenny EE, Trynka G, Einen M, et al. Immuno Chip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet 2013; 9: e1003270.
11. Guilleminault C, Pelayo R. Narcolepsy in prepubertal children. Ann Neurol 1998; 43: 135-42.
12. Hallmayer J, Faraco J, Lin L, Hesselson S, Winkelmann J, Kawashima M, et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 2009; 41: 708-11.
13. Han F, Lin L, Warby SC, Faraco J, Li J, Dong SX, et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 2011; 70: 410-7.
14. Hor H, Kutalik Z, Dauvilliers Y, Valsesia A, Lammers GJ, Donjacour CE, et al. Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet 2010; 42: 786-9.
15. Kawashima M, Lin L, Tanaka S, Jennum P, Knudsen S, Nevsimalova S, et al. Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy. Sleep 2010; 33: 869-74.
16. Kornum BR, Faraco J, Mignot E. Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain. Curr Opin Neurobiol 2011a; 21: 897-903.
17. Kornum BR, Kawashima M, Faraco J, Lin L, Rico TJ, Hesselson S, et al. Common variants in P2RY11 are associated with narcolepsy. Nat Genet 2011b; 43: 66-71.
18. Kotagal S, Hartse KM, Walsh JK. Characteristics of narcolepsy in preteenaged children. Pediatrics 1990; 85: 205-9.
19. Lecendreux M, Poli F, Oudiette D, Benazzouz F, Donjacour CE, Franceschini C, et al. Tolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: a retrospective study. Sleep 2012; 35: 709-11.
20. Luca G, Haba-Rubio J, Dauvilliers Y, Lammers GJ, Overeem S, Donjacour CE, et al. Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study. J Sleep Res 2013; 22: 482-95.
21. Ludvikova E, Nishino S, Sakai N, Jahn P. Familial narcolepsy in the Lipizzaner horse: a report of three fillies born to the same sire. Vet Q 2012; 32: 99-102.
22. Mascaro MB, Prosdócimi FC, Bittencourt JC, Elias CF. Forebrain projections to brainstem nuclei involved in the control of mandibular movements in rats. Eur J Oral Sci 2009; 117: 676-84.
23. Mignot E, Lin X, Arrigoni J, Macaubas C, Olive F, Hallmayer J, et al. DQB10602 and DQA10102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. Sleep 1994; 17 (Suppl 8): S60-7.
24. Mignot E, Lin L, Rogers W, Honda Y, Qiu X, Lin X, et al. Complex HLADR and-DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 2001; 68: 686-99.
25. Murali H, Kotagal S. Off-label treatment of severe childhood narcolepsycataplexy with sodium oxybate. Sleep 2006; 29: 1025-9.
26. Ohayon MM, Ferini-Strambi L, Plazzi G, Smirne S, Castronovo V. How age influences the expression of narcolepsy. J Psychosom Res 2005; 59: 399-405.
27. Overeem S, van Nues SJ, van der Zande WL, Donjacour CE, van Mierlo P, Lammers GJ. The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency. Sleep Med 2011; 12: 12-18.
28. Partinen M, Saarenpää-Heikkilä O, Ilveskoski I, Hublin C, Linna M, Olsén P, et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One 2012; 7: e33723.
29. Plazzi G, Pizza F, Palaia V, Franceschini C, Poli F, Moghadam KK, et al. Complex movement disorders at disease onset in childhood narcolepsy with cataplexy. Brain 2011; 134: 3480-92.
30. Poli F, Plazzi G, Di Dalmazi G, Ribichini D, Vicennati V, Pizza F, et al. Body mass index-independent metabolic alterations in narcolepsy with cataplexy. Sleep 2009; 32: 1491-7.
31. Poli F, Pizza F, Mignot E, Ferri R, Pagotto U, Taheri S, et al. High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy. Sleep 2013; 36: 175-81.
32. Ponz A, Khatami R, Poryazova R, Werth E, Boesiger P, Bassetti CL, et al. Abnormal activity in reward brain circuits in human narcolepsy with cataplexy. Ann Neurol 2010; 67: 190-200.
33. Rubboli G, d'Orsi G, Zaniboni A, Gardella E, Zamagni M, Rizzi R, et al. A video-polygraphic analysis of the cataplectic attack. Clin Neurophysiol 2000; 111 (Suppl 2): S120-8.
34. Schreyer S, Büttner-Ennever JA, Tang X, Mustari MJ, Horn AK. Orexin-A inputs onto visuomotor cell groups in the monkey brainstem. Neuroscience 2009; 164: 629-40.
35. Schwartz S, Ponz A, Poryazova R, Werth E, Boesiger P, Khatami R, et al. Abnormal activity in hypothalamus and amygdala during humour processing in human narcolepsy with cataplexy. Brain 2008; 131: 514-22.
36. Serra L, Montagna P, Mignot E, Lugaresi E, Plazzi G. Cataplexy features in childhood narcolepsy. Mov Disord 2008; 23: 858-65.
37. Sundvik M, Kudo H, Toivonen P, Rozov S, Chen YC, Panula P. The histaminergic system regulates wakefulness and orexin/hypocretin neuron development via histamine receptor H1 in zebrafish. FASEB J 2011; 25: 4338-47.
38. Tafti M, Villemin E, Carlander B, Besset A, Billiard M. Sleep in human narcolepsy revisited with special reference to prior wakefulness duration. Sleep 1992; 15: 344-51.
39. Vendrame M, Havaligi N, Matadeen-Ali C, Adams R, Kothare SV. Narcolepsy in children: a single-center clinical experience. Pediatr Neurol 2008; 38: 314-20.
40. Vetrugno R, D'Angelo R, Moghadam KK, Vandi S, Franceschini C, Mignot E, et al. Behavioural and neurophysiological correlates of human cataplexy: a video-polygraphic study. Clin Neurophysiol 2010; 121: 153-62.
41. Vignatelli L, Plazzi G, Peschechera F, Delaj L, D'Alessandro R. A 5-year prospective cohort study on health-related quality of life in patients with narcolepsy. Sleep Med 2011; 12: 19-23.
42. von Herrath M, Sanda S, Herold K. Type 1 diabetes as a relapsingremitting disease? Nat Rev Immunol 2007; 7: 988-94.
43. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107-14.
44. Yamuy J, Fung SJ, Xi M, Chase MH. Hypocretinergic control of spinal cord motoneurons. J Neurosci 2004; 24: 5336-45.